Dr Camidge and Sofia Diana Merajver, MD, PhD, reflected her lifelong journey shaped by immigration, intellectual curiosity, and a commitment to science in service of human health.
Sofia Diana Merajver, MD, PhD
Advertisement
Sofia Diana Merajver MD, PhD is the medical director of the Breast and Ovarian Cancer Risk Evaluation Program at the U-M Rogel Cancer Center.
Articles by Sofia Diana Merajver, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Priority Review to Frontline Dato-DXd for Metastatic TNBC Ineligible for Immunotherapy
2
Leveraging AI for Optimal Clinical Trial Design in Oncology
3
FDA Grants Fast Track Designation to Pelareorep Plus Bevacizumab/FOLFIRI in Second-Line KRAS-Mutant mCRC
4
Real-World Analysis Supports Rethinking Upfront Dose Intensity of Enfortumab Vedotin in Advanced Urothelial Cancer
5